A popular blood pressure and kidney medication has been recalled over concerns that capsules may not properly dissolve when ingested and lead to cardiac arrest.
Glenmark Pharmaceuticals and American Health Packaging (on behalf of BluePoint Laboratories) voluntarily recalled a total of 135 batches of Potassium Chloride, which is used to treat high blood pressure and prevent kidney failure.
According to the FDA, Glenmark pulled 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. American Health Packaging recalled 21 batches of the same medication.
Click here for the batch numbers and expiration dates on recalled bottles of Glenmark Pharmaceuticals Potassium Chloride.
Click here for the batch numbers and expiration dates on recalled bottles of American Health Packaging Potassium Chloride.
Both manufacturers’ recalled products were sold nationwide.
Recalled Blood Pressure Medication May Cause Hyperkalemia
The FDA announcements explained that if the capsules do not dissolve correctly, they can cause hyperkalemia. Someone with hyperkalemia—or elevated blood potassium levels—may experience an “irregular heartbeat that can lead to cardiac arrest” as well as cardiac arrhythmias and severe muscle weakness. If you’re having any of the above symptoms, seek medical attention immediately.
If you are taking the recalled medication, the FDA asks that you speak to your doctor if you’re experiencing early hyperkalemia symptoms. The administration also suggests speaking to your healthcare provider before abruptly stopping your medication.
You can find the source of this story’s featured image here.
Want to be happier in just 5 minutes a day? Sign up for Morning Smile and join over 455,000+ people who start each day with good news.
